Founded in 2021, EvodiaBio is a Danish industrial biotech company that uses precision-fermentation to produce natural monoterpene aromas with far lower resource use and CO₂ emissions than traditional extraction methods. Its Yops technology platform has already been deployed in more than 70 commercial brews and over 10 projects with top-40 breweries worldwide, and the firm has formed channel partnerships with Symrise and Lallemand. In just three and a half years the team moved from academic research to fully approved industrial production and has launched a profitable product line. Management now plans to accelerate growth in existing markets while expanding into Asia and adjacent sectors such as wine and broader aroma applications. The company reports “profitable from day one” unit economics and rapid commercial traction. To date EvodiaBio has secured €20 million across three funding rounds, including a €7 million raise last year and the latest €6 million round announced today.

Total raised

$21M

Funding rounds

3

Latest round

Equity

Latest activity

Dec 2025